Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103


A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype.

Kranzler HR, Armeli S, Tennen H, Covault J, Feinn R, Arias AJ, Pettinati H, Oncken C.

J Clin Psychopharmacol. 2011 Feb;31(1):22-30. doi: 10.1097/JCP.0b013e31820465fa. Erratum in: J Clin Psychopharmacol. 2011 Oct;31(5):576.


Post-treatment outcomes in a double-blind, randomized trial of sertraline for alcohol dependence.

Kranzler HR, Armeli S, Tennen H.

Alcohol Clin Exp Res. 2012 Apr;36(4):739-44. doi: 10.1111/j.1530-0277.2011.01659.x. Epub 2011 Oct 7.


5-HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensity.

Kranzler HR, Armeli S, Tennen H, Covault J.

Addict Biol. 2013 Nov;18(6):1024-31. doi: 10.1111/adb.12007. Epub 2012 Nov 12.


A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.

Kenna GA, Zywiak WH, McGeary JE, Leggio L, McGeary C, Wang S, Grenga A, Swift RM.

Alcohol Clin Exp Res. 2009 Feb;33(2):315-23. doi: 10.1111/j.1530-0277.2008.00835.x. Epub 2008 Nov 19.


Comparison of alcoholism subtypes as moderators of the response to sertraline treatment.

Kranzler HR, Feinn R, Armeli S, Tennen H.

Alcohol Clin Exp Res. 2012 Mar;36(3):509-16. doi: 10.1111/j.1530-0277.2011.01609.x. Epub 2011 Sep 6.


Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study.

Kenna GA, Zywiak WH, Swift RM, McGeary JE, Clifford JS, Shoaff JR, Vuittonet C, Fricchione S, Brickley M, Beaucage K, Haass-Koffler CL, Leggio L.

Alcohol Clin Exp Res. 2014 Jun;38(6):1567-74. doi: 10.1111/acer.12410. Epub 2014 Apr 28.


Differential effect of the 5-HTT gene-linked polymorphic region on emotional eating during stress exposure following tryptophan challenge.

Markus CR, Verschoor E, Smeets T.

J Nutr Biochem. 2012 Apr;23(4):410-6. doi: 10.1016/j.jnutbio.2011.01.005. Epub 2011 Jun 11.


Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype.

Pettinati HM, Volpicelli JR, Kranzler HR, Luck G, Rukstalis MR, Cnaan A.

Alcohol Clin Exp Res. 2000 Jul;24(7):1041-9.


Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings.

Kenna GA, Zywiak WH, Swift RM, McGeary JE, Clifford JS, Shoaff JR, Fricchione S, Brickley M, Beaucage K, Haass-Koffler CL, Leggio L.

Alcohol. 2014 Sep;48(6):515-22. doi: 10.1016/j.alcohol.2014.04.005. Epub 2014 Aug 14.


Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial.

Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R.

J Clin Psychopharmacol. 2003 Dec;23(6):553-62.


Variation in the gene encoding the serotonin transporter is associated with a measure of sociopathy in alcoholics.

Herman AI, Conner TS, Anton RF, Gelernter J, Kranzler HR, Covault J.

Addict Biol. 2011 Jan;16(1):124-32. doi: 10.1111/j.1369-1600.2009.00197.x.


Association between serotonin transporter gene promoter-region polymorphism and 4- and 12-week treatment response to sertraline in posttraumatic stress disorder.

Mushtaq D, Ali A, Margoob MA, Murtaza I, Andrade C.

J Affect Disord. 2012 Feb;136(3):955-62. doi: 10.1016/j.jad.2011.08.033. Epub 2011 Sep 29.


Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.

Brunoni AR, Kemp AH, Shiozawa P, Cordeiro Q, Valiengo LC, Goulart AC, Coprerski B, Lotufo PA, Brunoni D, Perez AB, Fregni F, BenseƱor IM.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1530-40. doi: 10.1016/j.euroneuro.2013.03.009. Epub 2013 Apr 21.


Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial.

O'Malley SS, Robin RW, Levenson AL, GreyWolf I, Chance LE, Hodgkinson CA, Romano D, Robinson J, Meandzija B, Stillner V, Wu R, Goldman D.

Alcohol Clin Exp Res. 2008 Jul;32(7):1271-83. doi: 10.1111/j.1530-0277.2008.00682.x.


Differential effects of 5-HTTLPR genotypes on inhibition of negative emotional information following acute stress exposure and tryptophan challenge.

Markus CR, De Raedt R.

Neuropsychopharmacology. 2011 Mar;36(4):819-26. doi: 10.1038/npp.2010.221. Epub 2010 Dec 8.


Differential effects of tri-allelic 5-HTTLPR polymorphisms in healthy subjects on mood and stress performance after tryptophan challenge.

Markus CR, Firk C.

Neuropsychopharmacology. 2009 Dec;34(13):2667-74. doi: 10.1038/npp.2009.92. Epub 2009 Aug 12.


5-HTTLPR moderates naltrexone and psychosocial treatment responses in heavy drinking men who have sex with men.

Chen AC, Davis CM, Kahler CW, Kuerbis AN, Covault J, Kranzler HR, Morgenstern J.

Alcohol Clin Exp Res. 2014 Sep;38(9):2362-8. doi: 10.1111/acer.12492. Epub 2014 Jul 28.


A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.

Pettinati HM, Oslin DW, Kampman KM, Dundon WD, Xie H, Gallis TL, Dackis CA, O'Brien CP.

Am J Psychiatry. 2010 Jun;167(6):668-75. doi: 10.1176/appi.ajp.2009.08060852. Epub 2010 Mar 15.


Serotonin transporter genotype and function in relation to antidepressant response in Koreans.

Myung W, Lim SW, Kim S, Kim H, Chung JW, Seo MY, Kim JW, Carroll BJ, Kim DK.

Psychopharmacology (Berl). 2013 Jan;225(2):283-90. doi: 10.1007/s00213-012-2813-y. Epub 2012 Aug 12.


Supplemental Content

Support Center